Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 17, 2013Clinical Pharmacology & Therapeutics

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update

View Full Paper
Ask AI
Bookmark
Share

Authors

Mary V. RellingMary V. RellingNorthwestern UniversityEGE E GardnerJohns Hopkins UniversityWSW. SandbornBD Biosciences (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Relling et al. (2013) studied this question.

synapsesocial.com/papers/6a81c5dd080e7f4ac74d7a99https://doi.org/10.1038/clpt.2013.4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients2011 · 88 citations
  2. 2Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy2010 · 141 citations
  3. 3CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network2011 · 1,185 citations
  4. 4Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing2011 · 575 citations
  5. 5Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity*12004 · 133 citations